Cost-Effectiveness of Fidaxomicin for Clostridium difficile Treatment

被引：2
|
作者：
Simon, Matthew S. [1 ,2 ]
机构：
[1] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA
[2] Weill Cornell Med Coll, Dept Publ Hlth, New York, NY 10065 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2014年 / 58卷 / 04期
关键词：
VANCOMYCIN; INFECTION; CANCER;
D O I：
10.1093/cid/cit772
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Safety and efficacy of fidaxomicin in the treatment of Clostridium difficile-associated diarrhea
    Golan, Yoav
    Epstein, Lauren
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2012, 5 (06): : 395 - 402
  • [22] Effectiveness of early use of fidaxomicin in preventing recurrence of Clostridium difficile infection
    Goldenberg, S. D.
    Wigglesworth, N.
    Wade, P.
    Price, N. M.
    JOURNAL OF HOSPITAL INFECTION, 2019, 102 (03) : 352 - 353
  • [23] Extended-pulsed fidaxomicin versus vancomycin in patients 60years and older with Clostridium difficile infection: cost-effectiveness analysis in Spain
    Rubio-Terres, Carlos
    Maria Aguado, Jose
    Almirante, Benito
    Cobo, Javier
    Grau, Santiago
    Salavert, Miguel
    Antona Sanchez, Elena Gonzalez
    Lopez Gutierrez, Cristina
    Rubio-Rodriguez, Dario
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2019, 38 (06) : 1105 - 1111
  • [24] Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection
    Miller, Mark
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (09) : 1569 - 1578
  • [25] Cost-Effectiveness Analysis of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
    Varier, Raghu U.
    Biltaji, Eman
    Smith, Kenneth J.
    Roberts, Mark S.
    Jensen, M. Kyle
    LaFleur, Joanne
    Nelson, Richard E.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2015, 36 (04) : 438 - 444
  • [26] Fidaxomicin for treatment of clostridium difficile-associated diarrhea and its potential role for prophylaxis
    Hostler, Christopher J.
    Chen, Luke F.
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (11) : 1529 - 1536
  • [27] Fidaxomicin Inhibits Spore Production in Clostridium difficile
    Babakhani, Farah
    Bouillaut, Laurent
    Gomez, Abraham
    Sears, Pamela
    Ly Nguyen
    Sonenshein, Abraham L.
    CLINICAL INFECTIOUS DISEASES, 2012, 55 : S162 - S169
  • [28] Fidaxomicin inhibits toxin production in Clostridium difficile
    Babakhani, Farah
    Bouillaut, Laurent
    Sears, Pamela
    Sims, Carlee
    Gomez, Abraham
    Sonenshein, Abraham L.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (03) : 515 - 522
  • [29] Outcomes With Fidaxomicin Therapy in Clostridium difficile Infection
    Spiceland, Clayton M.
    Khanna, Sahil
    Pardi, Darrell S.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2018, 52 (02) : 151 - 154
  • [30] Fidaxomicin - the new drug for Clostridium difficile infection
    Vaishnavi, Chetana
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2015, 141 : 398 - 407
12345